... examined the safety of combining gemcitabine with bevacizumab and radiotherapy in patients with operable pancreatic cancer. In the study, 14 patients with potentially operable tumors completed the ...
Treating pancreatic cancer with a combination of chemotherapy, biotherapy and radiotherapy prior to surgery is safe and may be beneficial for patients, according to a new study. In the preliminary ...
... of the biomarker panel they have assembled to see how well it distinguishes between pancreatitis and pancreatic cancer. The researchers also want to continue testing the value of a biomarker-panel ...
CHICAGO (AP) -- As a doctor, Ron Davis knew what it meant when he got a diagnosis of advanced pancreatic cancer earlier this year....
... it in clinical studies.
The results indicated that the CGT approach not only prevented pancreatic cancer growth and progression, but it also effectively killed established tumors, thereby displaying ...
... a phase II trial of patients with inoperable pancreatic cancer, researchers report at the 33rd Congress ... I have ever seen in palliative treatment in pancreatic cancer," Prof. Löhr said. "The results ...
STOCKHOLM, Sweden, Sept. 17 (UPI) -- European medical scientists have determined a new form of chemotherapy extends the life of patients with inoperable pancreatic cancer.
... modalities. In this situation, another strategy for the chemoradiotherapy for locally advanced pancreatic cancer might be required, such as one in which the patients receive one or two cycles of ...
The treatment of pancreatic cancer remains a great challenge. The majority of patients with pancreatic cancer developed major depression. Antidepressant treatment has been accepted as one of the new ...
... of erlotinib. Treatment with anti-EGFR agents is used as a potential therapeutic strategy for pancreatic cancer, but the mechanisms are not yet precisely understood. This article was published on ...
PHILADELPHIA, Sept. 25 (UPI) -- U.S. scientists say they've created a technique in which nanoparticles are used to deliver a deadly diphtheria toxic gene that kills pancreatic cancer cells.
... in the future.
"We are working hard to try to understand the factors that are risks to developing pancreatic cancer, particularly modifiable risks," Abbruzzese said. "If these results are confirmed, ...
... University and the Kimmel Cancer Centre at Jefferson, has achieved a substantial 'kill' of pancreatic cancer cells by using nanoparticles to successfully deliver a deadly diphtheria toxin gene...
Pancreatic cancer is the fifth to sixth leading cause of cancer death in Europe and the fourth leading cause of cancer death in the USA. The lethality of this malignancy is demonstrated by the fact ...
Many gastrointestinal tumours, including pancreatic cancer, have been shown to overexpress the EGFR. The overexpression of EGFR correlates with rapidly progressive disease and poor prognosis...
